CLINICAL_TRIALS
trial_result
· 2024-11-06
Clinical Trial Update: A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus [Phase 2]
Summary
Phase 2 trial of JNJ-73763989 in people co-infected with hepatitis B and hepatitis D has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Research & Development, LLC | Conditions: Hepatitis D, Chronic | Phase 2 | Status: COMPLETED | Results posted: 2024-11-06